Skip to main content

LP 226 Pill - white capsule/oblong, 14mm

Pill with imprint LP 226 is White, Capsule/Oblong and has been identified as Theophylline Extended-Release 300 mg. It is supplied by Leading Pharma, LLC.

Theophylline is used in the treatment of Apnea of Prematurity; Asthma, Maintenance; Asthma; Asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LP 226

Theophylline Extended-Release

Imprint
LP 226
Strength
300 mg
Color
White
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Leading Pharma, LLC
National Drug Code (NDC)
69315-0226

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.